住院精神病患者合并糖尿病的用药调查  

Investigation on medication of inpatients with psychosis complicated with diabetes mellitus

作　　者：梁素霞[1] 李淑香[1] 郭汲源[1] Liang Suxia;Li Shuxiang;Guo Jiyuan(Beijing Minkang Hospital,Beijing 102206,China)

机构地区：[1]北京民康医院,北京102206

出　　处：《首都食品与医药》2024年第4期70-72,共3页Capital Food Medicine

摘　　要：目的 调查精神病患者合并糖尿病的用药情况.方法 通过检索住院患者合并糖尿病的诊断、合并症、降糖药物的使用情况,参照指南推荐药物对数据进行统计分析.结果 ①住院精神病患者糖尿病的患病率为28.0%(82/293),降糖药物使用率为95.1%(78/82);②2型糖尿病占76.8%(63/82),二甲双胍的使用率77.8%(49/63);③2型糖尿病伴ASCVD、慢性肾病、心力衰竭占71.4%(45/63),未使用GLP-1RA或SGLT2i.结论 建议积极推广使用指南推荐的性价比较高的新药.Objective To investigate the drug use of psychotic patients complicated with diabetes.Methods By collecting the diagnosis,complications and the use of hypoglycemic drugs of hospitalized patients with diabetes mellitus,the data were statistically analyzed with reference to the recommended drugs in the guidelines.Results ①The prevalence rate of diabetes mellitus in psychiatric inpatients was 28.0%(82/293),and the utilization rate of hypoglycemic drugs was 95.1%(78/82);②The proportion of type 2 diabetes mellitus was 76.8%(63/82),and the utilization rate of metformin was 77.8%(49/63);③Type 2 diabetes with ASCVD,chronic nephropathy and heart failure accounted for 71.4%(45/63),and GLP-1RA or SGLT2i was not used.Conclusions It is suggested to actively promote the use of new drugs with high cost performance recommended by the guide.

关 键 词：精神病 糖尿病 合理用药 现况调查 数据分析 

分 类 号：R969.3[医药卫生—药理学]